SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹18 Cr | ₹23 Cr | ₹28 Cr | ₹10 Cr | ₹6.24 Cr |
What is the latest Consolidated Net Profit of SHREE GANESH REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹28 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.24 Cr |
How is Consolidated Net Profit of SHREE GANESH REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | -23.01 | |
| Mar2025 | ₹23 Cr | -17.93 | |
| Mar2024 | ₹28 Cr | 168.44 | |
| Mar2020 | ₹10 Cr | 67.94 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Consolidated Net Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹872.6 Cr | -5% | 2.4% | 31.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5% |
2.4% |
31.9% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses